Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Cancer Research|February 3, 2006
Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxiaUrban Emmenegger, Gerard C Morton, Giulio Francia, et al.
Oncotarget|February 2, 2017
The antiangiogenic role of the pro-inflammatory cytokine interleukin-31Shiri Davidi, Ella Fremder, Tal Kan, et al.
Cancer Research|September 10, 2009
Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1Chris Folkins, Yuval Shaked, Shan Man, et al.
Plos One|December 20, 2007
Id1 restrains p21 expression to control endothelial progenitor cell formationAlessia Ciarrocchi, Vladimir Jankovic, Yuval Shaked, et al.
Neoplasia (New York, N.Y.)|June 25, 2014
Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapyErez Hasnis, Dror Alishekevitz, Svetlana Gingis-Veltski, et al.
Journal of Leukocyte Biology|April 30, 2008
An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic miceDaniel Voskas, Yael Babichev, Ling S Ling, et al.
Cancer Research|September 28, 2011
Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growthMichael C Schmid, Christie J Avraamides, Philippe Foubert, et al.
Cancer Research|October 8, 2011
Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in miceSvetlana Gingis-Velitski, David Loven, Liat Benayoun, et al.
Frontiers in Oncology|September 9, 2020
Intratumoral HLA-DR<sup>-</sup>/CD33<sup>+</sup>/CD11b<sup>+</sup> Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerErez Hasnis, Aviva Dahan, Wissam Khoury, et al.
Blood|June 21, 2011
G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonistTali Voloshin, Svetlana Gingis-Velitski, Rotem Bril, et al.
Pageof 14